Finding advanced prostate cancers

For men who choose prostate cancer screening, it begins with measuring prostate-specific antigen (PSA) in the blood. Scientists continue to explore strategies beyond PSA testing to identify men who should have biopsies because they are more likely to have intermediate or high-risk cancer. These strategies include other types of PSA measurements, urine tests for genes, new imaging methods and artificial intelligence that works to improve the accuracy and efficiency of MRI and biopsies.